


Searching News Database: nanotechnology
HSMN NewsFeed - 14 Dec 2023
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 29 Mar 2022
Medline and Hologenix Partner on New Curad Performance Series Line Powered By Celliant
Medline and Hologenix Partner on New Curad Performance Series Line Powered By Celliant
HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
HSMN NewsFeed - 3 Feb 2020
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
HSMN NewsFeed - 14 Oct 2019
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
HSMN NewsFeed - 11 Feb 2019
BioDirection Receives Breakthrough Device Designation from FDA for Tbit(TM) System
BioDirection Receives Breakthrough Device Designation from FDA for Tbit(TM) System
HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
HSMN NewsFeed - 15 Jul 2016
Leica Microsystems Introduces A New Distribution Partner, Angstrom Scientific
Leica Microsystems Introduces A New Distribution Partner, Angstrom Scientific
HSMN NewsFeed - 24 Aug 2015
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
HSMN NewsFeed - 18 Mar 2015
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
HSMN NewsFeed - 3 Sep 2014
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
HSMN NewsFeed - 30 Oct 2012
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
HSMN NewsFeed - 16 Dec 2009
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
HSMN NewsFeed - 15 Dec 2009
Gamma Medica-Ideas Licenses Molecular Breast Imaging Technology From Mayo Clinic
Gamma Medica-Ideas Licenses Molecular Breast Imaging Technology From Mayo Clinic
HSMN NewsFeed - 10 Sep 2009
Stem Cell Therapy International Inc. Announces Histostem Litigation Settlement
Stem Cell Therapy International Inc. Announces Histostem Litigation Settlement
HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
HSMN NewsFeed - 16 Apr 2009
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
HSMN NewsFeed - 14 Apr 2009
Oasmia: FDA Grants Paclical(r) Orphan Drug Designation for Ovarian Cancer in the USA
Oasmia: FDA Grants Paclical(r) Orphan Drug Designation for Ovarian Cancer in the USA
HSMN NewsFeed - 8 Apr 2009
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
HSMN NewsFeed - 16 Oct 2008
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
HSMN NewsFeed - 14 Oct 2008
Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
HSMN NewsFeed - 12 Sep 2008
Varian Medical Systems Signs Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia
Varian Medical Systems Signs Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia
HSMN NewsFeed - 16 Jun 2008
NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
HSMN NewsFeed - 28 Apr 2008
Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
HSMN NewsFeed - 25 Mar 2008
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market Next Generation Pedicle Screw System
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market Next Generation Pedicle Screw System
HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
HSMN NewsFeed - 17 Apr 2007
Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
HSMN NewsFeed - 10 Apr 2007
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
HSMN NewsFeed - 26 Dec 2006
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
HSMN NewsFeed - 10 Nov 2006
Talyst Receives $20 Million Funding to Accelerate Growth of Medication Safety Systems
Talyst Receives $20 Million Funding to Accelerate Growth of Medication Safety Systems
HSMN NewsFeed - 10 Nov 2006
CombiMatrix Molecular Diagnostics Announces the Launch of Powerful New Melanoma Test
CombiMatrix Molecular Diagnostics Announces the Launch of Powerful New Melanoma Test
HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
HSMN NewsFeed - 12 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
HSMN NewsFeed - 12 Jul 2006
Biophan Announces Key Senate Approval of $400,000 for the MYO-VAD Cardiac Assist Device
Biophan Announces Key Senate Approval of $400,000 for the MYO-VAD Cardiac Assist Device
HSMN NewsFeed - 26 Jun 2006
CombiMatrix Molecular Diagnostics to Offer First Commercial Genetic Test from Its CLIA Certified Laboratory
CombiMatrix Molecular Diagnostics to Offer First Commercial Genetic Test from Its CLIA Certified Laboratory
HSMN NewsFeed - 25 May 2006
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
Additional items found! 81
Members Archive contains
81 additional stories matching:
nanotechnology
(Password required)
nanotechnology
(Password required)
